Friday, July 10, 2026

Drug profile · INN

iothalamate meglumine

iothalamate meglumine (VASCORAY) is a diagnostic agent. Route of administration: intravesical, ureteral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — iothalamate meglumine
US status
approved
Class
Route
INTRAVESICAL, URETERAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

iothalamate meglumine (VASCORAY) is a diagnostic agent. Route of administration: intravesical, ureteral. Current US regulatory status: approved.

Key facts

INN iothalamate meglumine
Brand VASCORAY
Mechanism Diagnostic agent
Route INTRAVESICAL, URETERAL
Formulation INJECTABLE

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is iothalamate meglumine?

iothalamate meglumine (VASCORAY) is a diagnostic agent. Route of administration: intravesical, ureteral. Current US regulatory status: approved.

What is the brand name for iothalamate meglumine?

VASCORAY is a marketed brand name for iothalamate meglumine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of iothalamate meglumine?

iothalamate meglumine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.